Clinical Trial

A Novel Approach in the Evaluation of Breast Masses With Doppler US

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 16, 2026 (before its estimated May 5, 2026 completion). Its status may not reflect the trial's current state.
Summary
In cases with breast masses, Doppler resistive index values will be calculated for the mass and surrounding healthy tissue and the opposite healthy breast tissue, and their effect on distinguishing between benign and malignant masses will be evaluated.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-03-06.
Trial Details
NCT Number NCT07465523
Lead Sponsor Ahmet Yesildag
Conditions Breast Neoplasm Female, Benign Breast Neoplasm, Malign Breast Neoplasm, Doppler Ultrasound Diagnosis
Enrollment 90 participants
Start Date 2026-03-04
Primary Completion 2026-05-05 (estimated)
Study Completion 2026-05-19 (estimated)
Updated on ClinicalTrials.gov 2026-03-16